* Conmed Corp CNMD.N CNMD.K is expected to show a rise
in
quarterly revenue when it reports results on January 31 for the
period ending December 31 2023
* The Largo Florida-based company is expected to report a
32.4% increase in revenue to $332.198 million from $250.87
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Conmed Corp is for
earnings of
$1.11 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Conmed Corp
is
$122.50, above its last closing price of $92.04.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.83 0.83 0.90 Beat 8.4
Jun. 30 2023 0.79 0.79 0.83 Beat 4.5
Mar. 31 2023 0.60 0.60 0.66 Beat 10.3
Dec. 31 2022 0.89 0.90 0.42 Missed -53.5
Sep. 0.75 0.75 0.77 Beat 2.4
30 2022
Jun. 30 2022 0.74 0.75 0.76 Beat 1.8
Mar. 31 2022 0.62 0.62 0.70 Beat 13.3
Dec. 31 2021 1.03 1.03 1.07 Beat 4
This summary was machine generated January 29 at 21:02 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)